Skip to main content
Erschienen in: Journal of Translational Medicine 1/2017

Open Access 01.12.2017 | Research

Application of survival tree analysis for exploration of potential interactions between predictors of incident chronic kidney disease: a 15-year follow-up study

verfasst von: Azra Ramezankhani, Maryam Tohidi, Fereidoun Azizi, Farzad Hadaegh

Erschienen in: Journal of Translational Medicine | Ausgabe 1/2017

Abstract

Background

Chronic kidney disease (CKD) is a growing public health challenges worldwide. Various studies have investigated risk factors of incident CKD; however, a very few studies examined interaction between these risk factors. In an attempt to clarify the potential interactions between risk factors of CKD, we performed survival tree analysis.

Methods

A total of 8238 participants (46.1% men) aged > 20 years without CKD at baseline [(1999–2001) and (2002–2005)], were followed until 2014. The first occurrence of CKD, defined as the estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2, was set as the main outcome. Multivariable Cox proportional hazard (Cox PH) regression was used to identify significant independent predictors of CKD; moreover, survival tree analysis was performed to gain further insight into the potential interactions between predictors.

Results

The crude incidence rates of CKD were 20.2 and 35.2 per 1000 person-years in men and women, respectively. The Cox PH identified the main effect of significant predictors of CKD incidence in men and women. In addition, using a limited number of predictors, survival trees identified 12 and 10 subgroups among men and women, respectively, with different survival probability. Accordingly, a group of men with eGFR > 74 ml/min/1.73 m2, age ≤ 46 years, low level of physical activity, waist circumference ≤ 100 cm and FPG ≤ 4.7 mmol/l had the lowest risk of CKD incidence; while men with eGFR ≤ 63.4 ml/min/1.73 m2, age > 50 years had the highest risk for CKD compared to men in the lowest risk group [hazard ratio (HR), 70.68 (34.57–144.52)]. Also, a group of women aged ≤ 45 years and eGFR > 83.5 ml/min/1.73 m2 had the lowest risk; while women with age > 48 years and eGFR ≤ 69 ml/min/1.73 m2 had the highest risk compared to low risk group [HR 27.25 (19.88–37.34)].

Conclusion

In this post hoc analysis, we found the independent predictors of CKD using Cox PH; furthermore, by applying survival tree analysis we identified several numbers of homogeneous subgroups with different risk for incidence of CKD. Our study suggests that two methods can be used simultaneously to provide new insights for intervention programs and improve clinical decision making.
Abkürzungen
AIC
Akaike information criteria
BMI
body mass index
CI
confidence interval
CKD
chronic kidney disease
CVD
cardiovascular disease
Cox PH
Cox proportional hazards
DBP
diastolic blood pressure
eGFR
estimated glomerular filtration rate
ESRD
end stage renal disease
FHD
family history of diabetes
FPG
fasting plasma glucose
HR
hazard ratios
IQR
inter quartile range
KM
Kaplan–Meier
MET
metabolic equivalent of task
MDRD
modification of diet in the renal disease study
PAL
physical activity level
PH
proportional hazards
PS
propensity score
SBP
systolic blood pressure
TC
total cholesterol
TGs
triglycerides
TLGS
Tehran Lipid and Glucose Study
WC
waist circumference

Background

Chronic kidney disease (CKD) is a growing public health challenges worldwide [1]. CKD is a major cause of not only progression to renal failure, but also excess cardiovascular morbidity and mortality. It affects 10–15% of the adult population around the world [1, 2]. In recent years, a silent CKD epidemic has been proposed by many authors [3, 4]. The outbreak is because of the inclusion of a large proportion of the elderly population within stage 3 CKD [5]. Also, in the developing countries, up to 40% of those identified with CKD in screening programs were often young [4]. Because early interventions could prevent or postpone the progression to end stage renal disease (ESRD), identification of risk factors is a major step in dealing with the CKD epidemic [6, 7].
The primary method for identifying predictors of incident CKD has been use of traditional regression models such as logistic or Cox proportional hazards (Cox PH) model. However, assessment of interactions in the presence of a large number of variables leads to a complicated model that can be difficult to fit and interpret [810]. For example, if we have 20 covariates, then there are (20 × 19)/2 = 190 two-factor interaction terms for including into regression models. On the other hand, if many interactions are examined and only the strongest included in the regression model, this would contribute to biased estimation of the effects and overly optimistic performance estimates [11]. Hence, in prediction of CKD, many studies have examined the interactions between only important risk factors such as hypertension or diabetes with other factors [12, 13].
Recursive partitioning or ‘decision trees’ are another class of nonparametric regressions which are widely used in many fields [1417]. Survival trees are popular nonparametric alternatives to the Cox PH model, which have great flexibility and can automatically detect certain types of interactions. Moreover, they can naturally group subjects according to their length of survival based on their covariates patterns [11, 14, 18, 19]. The aims of the present study, conducted among Iranian adult population, were to investigate (1) the independent predictors of incident CKD separately among men and women using traditional statistical method and (2) the potential interactions between predictors to identify different risk groups for CKD incidence using survival tree analysis. We used data from the Tehran Lipid and Glucose Study (TLGS) for our investigation.

Methods

Study population

The TLGS is an ongoing community-based prospective study performed on a representative sample of residents of Tehran, the capital of the Islamic Republic of Iran. This city composed of 22 urban districts. Study samples were selected from the district 13. The rationales for choosing district 13 were: (1) high stability of the population residing in that district compared to other districts of Tehran, and (2) the age distribution of the population of district 13 was representative of the overall population of Tehran. At first phase of study (1999–2002), a multistage stratified cluster random sampling technique was used to select more than 15,000 people aged ≥ 3 year. The participants then were followed in four consecutive phases, i.e. 2002–2005 (phase 2), 2005–2008 (phase 3), 2008–2011 (phase 4) and the final survey in 2011–2014 (phase 5). Another 3551 residents were invited for the second phase and were followed in the next 3 phases. The details of the study have been published elsewhere [20]. The present study was a post hoc analysis of the TLGS. A total of 12,808 adult participants aged ≥ 20 year from the first and second phases were selected as baseline population and the cohort was re-examined at next phases until the phase 5. Among this participants, we excluded subjects with prevalent CKD (n = 2061) at baseline, and those with missing data on creatinine level (n = 414). Finally, after excluding those without any follow-up data after recruitment (n = 2095), 8238 participants (3795 men and 4443 women) (80% of eligible subjects) were followed until the end of study (Fig. 1). This study was approved by the ethical committee of the Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences, Tehran, Iran, and conducted in accordance with the Declaration of Helsinki. All participants signed informed consent forms.

Clinical, anthropometric and laboratory measurements

At baseline, information on demographics, education, smoking status, medical and drug history was collected using interview. Anthropometric measures including body weight and height, hip, wrist and waist circumferences (WC) were measured according to a standard protocol. Body mass index (BMI) was calculated as weight in kilogram divided by the square of height in meter. Blood pressure was measured twice and mean of two measurements was considered as the participant’s blood pressure. Blood samples were drawn after an overnight fast of ≥ 12 h to assess the following parameters: fasting plasma glucose (FPG) (measured by the enzymatic colorimetric glucose oxidase); total cholesterol (TC) and triglycerides (TGs) (were assayed using the enzymatic colorimetric method) and the Serum creatinine (cr) level which was assayed by kinetic colorimetric Jaffe using commercial kits (Pars Azmoon Inc., Tehran, Iran) by a Selectra 2 auto analyzer (Vital Scientific, Spankeren, The Netherlands) [20, 21]. The sensitivity of the assay was 0.2 mg/dl. Reference intervals according to manufacturer’s recommendation were 53–97 mmol/l (0.6–1.1 mg/dl) and 80–115 mmol/l (0.9–1.3 mg/dl) in women and men respectively. Both intra-assay and inter-assay CVs were less than 3.1% in both baseline and follow-up phases. Assay performance was monitored after every 25 tests using lyophilized serum controls in normal and abnormal ranges and all samples were assayed when internal quality control met the standard satisfactory criteria [17, 18]. In the first phase, physical activity level (PAL) was assessed by the lipid research clinic questionnaire (LRC) [22], which was validated for this study [23]. LRC is one of the most common questionnaires to assess PAL in large-scale epidemiological studies [24]. It was replaced by the Modifiable Activity Questionnaire (MAQ) from the 2nd phase for obtaining the quantitative measure of PAL. This questionnaire measures all three forms of activities including leisure time, job, and household activities in the past year [25].

Definition of variables and outcomes

Kidney function was estimated by the estimated glomerular filtration rate (eGFR) that was calculated using the modification of diet in renal disease (MDRD) equation [26]. The definition of incident CKD was an eGFR of < 60 ml/min per 1.73 m2 (CKD Stage 3–5) occurring at any time during the follow-up period. Educational status was categorized to 4 levels as illiterate, 1–9 years, 10–12 years and over 12 years of schooling. Marital status was categorized as single, married, and widowed/divorced. Different categories of smoking status were defined according to WHO guidelines [27]. A current smoker was defined as a person who smokes cigarettes or other smoking implements (water-pipes, or pipes) at least once a day or occasionally. Ex-smoker was formerly daily or occasional smoker who currently does not smoke and non-smoker defined as people who never smoked before. A family history of premature cardio-vascular diseases (CVDs) was considered as any experience of fatal or non-fatal myocardial infarction, stroke or sudden cardiac arrest in first-degree relatives, if it occurred before 55 year of age in male relatives (father, brother and son) and before 65 year of age in female relatives (mother, sister and daughter). Family history of diabetes (FHD) was defined as having type 2 diabetes in first-degree relatives. In first phase, physically active participants were identified as those who were participating in a vigorous physical activity at least 3 days per week [22], and in the second phase, it was defined as achieving a minimum of at least 600 MET (metabolic equivalent task)-minutes per week [28].

Statistical analyses

Descriptive statistics (mean, SD, proportion) were used to describe baseline characteristics. Comparison of baseline characteristics between men vs. women, between participants with and without incident CKD and between followed and non-followed participants was done using student’s t test, Chi square and Mann–Whitney test, as appropriate. Incidence density rate of CKD and respective 95% confidence interval (CI) were calculated for each gender, by dividing the number of events to person-years at risk. Time to event was defined as time of censoring or date of incidence of CKD, whichever occurred first. The event date for the incident cases of CKD was defined as midtime between the date of follow-up visit at which the CKD was diagnosed for the first time, and the most recent follow-up visit prior to the diagnosis. For censored subjects, the time was the interval between the first and the last observation dates. Study participants were censored due to death, loss to follow-up, or the end of the observation period. The Stepwise Cox PH regression model using Akaike information criteria (AIC), as model selection approach, was used to identify significant predictors of incident CKD by calculating multivariable hazard ratios (HRs) with 95% CI (after confirming the proportionality in the model). Due to significant effect modification of gender on FPG, SBP, diastolic blood pressure (DBP), eGFR and WC (all p < 0.05), we stratified our analysis by gender. Moreover, for examination of the gender effect in the multivariable model we fitted the Cox PH model on whole population. In further analysis, conditional survival tree was implemented with the same outcome and covariates as for Cox method [29]. In step 1, among m covariate, survival tree algorithm selects the variable X i with the highest ability to separate survivors and non-survivors using p-values from permutation distributions. In step 2, in order to split X i into two disjoint sets (dichotomizing), the algorithm first sorts the values of X i in increasing order. Typically, the midpoint between each pair of adjacent values is considered as a possible cut-point. Therefore, given v values of X i , then v-1 possible splits are evaluated. For each possible cut-point for X i , the value of the log-rank statistic associated with the considered cut-point is computed; then, the cut-point associated with the smallest p-value is selected. This procedure is applied recursively until the tree grew to an optimal number of terminal nodes. A survival tree can naturally group subjects according to their survival time and based on their covariates; hence, it automatically detects complex interactions between covariates without the need to specify them beforehand. In the present study, all baseline variables were entered for constructing survival trees. The minimum criterion for node split was defined as p < 0.05 and the minimum final nodes size were defined as 100 persons. Kaplan–Meier (KM) curves were constructed for each subgroup identified by the survival tree. Also, according the number of subgroups were found by survival tree, we specified one categorical variables with k level (k is the number of terminal nodes or subgroups in survival trees) and estimated the HR of CKD events among the identified subgroups by considering the low risk group (highest survival probability) as the reference category. We used two packages of Party and Survival from the R software (http://​www.​r-project.​org/​) for the analysis. Two-tailed p-values < 0.05 were considered statistically significant.

Results

Study participants and baseline characteristics

The study sample consisted of 3795 men, aged 20–84 year (mean, 41.4 ± 14.1) and 4443 women, aged 20–83 year (mean, 37.5 ± 12.1). Table 1 shows the baseline characteristics of the participants. There was a gender difference in all baseline variables except for TC, family history of premature CVD in male relatives, PAL and use of blood glucose lowering drugs. Women were younger and had lower eGFR, WC, wrist circumference, FPG, SBP and DBP, but had higher BMI, hip circumference and heart rate, compared with men (Table 1).
Table 1
Baseline characteristics of the study subjects in the TLGS cohort, Tehran Lipid and Glucose Study (1999–2014)
Variables
Total
n = 8238
Gender difference
p-value
Men
n = 3795
Women
n = 4443
Age (years)
39.3 (13.3)
41.4 (14.2)
37.5 (12.1)
0.001
Total length of stay in the city (years)
32.9 (13.1)
34.6 (13.2)
31.5 (12.8)
0.001
BMI (kg/m2)
26.5 (4.7)
25.8 (4.1)
27.1 (5.1)
0.001
Waist circumference (cm)
87.4 (12.3)
89.1 (11.5)
86.1 (12.8)
0.001
Wrist circumference (cm)
16.7 (1.3)
17.7 (0.9)
15.9 (1.1)
0.001
Hip circumference (cm)
100.29 (9.17)
96.71 (7.23)
103.43 (9.54)
0.001
FPG (mmol/l)
4.9 (4.6–5.4)
5.1 (4.7–5.4)
4.9 (4.5–5.3)
0.001
TG (mmol/l)
1.5 (1.1–2.3)
1.7 (1.2–2.5)
1.4 (0.9–2.1)
0.001
TC (mmol/l)
5.2 (1.1)
5.1 (1.1)
5.2 (1.2)
0.07
HDL-C (mmol/l)
1.1 (0.3)
0.9 (0.2)
1.2 (0.3)
0.001
eGFR (ml/min/1.73 m2)
75.6 (10.5)
77.1 (10.8)
74.3 (10.1)
0.001
SBP (mmHg)
116.5 (17.1)
118.8 (16.7)
114.6 (17.1)
0.001
DBP (mmHg)
76.4 (10.6)
77.1(10.7)
75.8 (10.5)
0.001
Heart rate (beats/min)
79.3 (11.5)
75.3 (9.8)
82.7 (11.7)
0.001
Education
 Level 1 (illiterate)
1754 (21.3)
739 (19.5)
1015 (22.8)
 
 Level 2 (< 9 years)
4831 (58.6)
2228 (58.7)
2603 (58.6)
0.001
 Level 3 (9–12 years)
1203 (14.6)
688 (18.1)
515 (11.6)
 
 Level 4 (> 12 years)
450 (5.5)
140 (3.7)
310 (7.0)
 
Marital status
 Single
1337 (16.2)
743 (19.6)
594 (13.4)
 
 Married
6625 (80.4)
3027 (79.8)
3598 (81.0)
0.001
 Divorced/widowed
276 (3.4)
25 (0.7)
251 (5.6)
 
FH-CVD in female relatives
669 (8.1)
267 (7.0)
402 (9.0)
0.001
FH-CVD in male relatives
657 (8.0)
310 (8.2)
347 (7.8)
0.568
FHD in first-degree relatives
2255 (27.4)
977 (25.7)
1278 (28.8)
0.002
PAL
 Inactivea
5458 (66.3)
2533 (66.7)
2925 (65.8)
0.802
Smoking
 Never
6207 (75.3)
2067 (54.5)
4140 (93.2)
 
 Past
567 (6.9)
510 (13.4)
57 (1.3)
0.001
 Current
1339 (16.3)
1158 (30.5)
181 (4.1)
 
Use of blood lipid lowering drugs
177 (2.1)
63 (1.7)
114 (2.6)
0.005
Use of blood glucose lowering drugs
234 (2.8)
100 (2.6)
134 (3.0)
0.319
Use of anti hypertensive drugs
335 (4.1)
113 (3.0)
222 (5.0)
0.001
Use of aspirin
717 (8.7)
394 (10.4)
323 (7.3)
0.001
Use of diuretics
93 (1.1)
22 (0.6)
71 (1.6)
0.001
Prevalence CVD
219 (2.7)
140 (3.7)
79 (1.8)
0.001
Figures are either mean (SD) or N (%) for continuously and categorically distributed variables, respectively
TLGS Tehran Lipid and Glucose Study, BMI body mass index, FPG fasting plasma glucose, TG triglyceride, TC total cholesterol, HDL-C HDL cholesterol, eGFR estimated glomerular filtration rate, SBP systolic blood pressure, DBP diastolic blood pressure, FH-CVD family history of premature cardiovascular disease, FHD family history of diabetes mellitus, PAL physical activity level, CVD cardiovascular disease
aDoing exercise or labor less than three times a week or performing activities achieving < 600 metabolic equivalent of task (MET)
A comparison of baseline characteristics between followed and non-followed subjects is shown in Table 2. Followed subjects had a significantly higher BMI (26.5 vs. 26.1 kg/m2), WC (87.4 vs. 86.3 cm), hip circumference (100.2 vs. 99.6 cm) and TC (5.2 vs. 5.1 mmol/l), but lower FPG (5.2 vs. 5.3 mmol/l) and eGFR (75.5 vs. 76.1) compared to non-followed subjects, respectively.
Table 2
Baseline characteristics of followed and non-followed subjects in the TLGS cohort, Tehran Lipid and Glucose Study (1999–2014)
Variables
Total
n = 10,333
Followed
n = 8238
Non-followed
n = 2095
Difference (95% CI)
Age (years)
39.24 (13.64)
39.29 (13.25)
39.02 (15.07)
0.27 (− 0.38, 0.92)
Total length of stay in the city (years)
32.68 (13.47)
32.88 (13.08)
31.88 (14.90)
1.00 (0.30, 1.69)
BMI (kg/m2)
26.44 (4.77)
26.50 (4.67)
26.20 (5.14)
0.29 (0.04, 0.54)
Waist circumference (cm)
87.23 (12.38)
87.42 (12.28)
86.47 (12.75)
0.95 (0.33, 1.56)
Wrist circumference (cm)
16.69 (1.34)
16.71 (1.34)
16.64 (1.32)
0.07 (0.01, 0.13)
Hip circumference (cm)
100.18 (9.34)
100.28 (9.17)
99.78 (9.98)
0.50 (0.02, 0.98)
FPG (mmol/l)
5.29 (1.59)
5.27 (1.53)
5.38 (1.83)
− 0.10 (− 0.19, − 0.01)
TG (mmol/l)
1.83 (1.33)
1.84 (1.34)
1.80 (1.33)
0.04 (− 0.02, 0.11)
TC (mmol/l)
5.16 (1.15)
5.17 (1.14)
5.11 (1.17)
0.05 (0.01, 0.11)
HDL-C (mmol/l)
1.07 (0.28)
1.07 (0.28)
1.07 (0.28)
− 0.00 (− 0.01, 0.01)
eGFR (mL/min/1.73 m2)
75.70 (10.53)
75.59 (10.49)
76.15 (10.70)
− 0.56 (− 1.07, − 0.04)
SBP (mmHg)
116.59 (17.40)
116.49 (17.05)
116.99 (18.74)
− 0.50 (− 1.33, 0.34)
DBP (mmHg)
76.34 (10.65)
76.39 (10.60)
76.15 (10.81)
0.23 (− 0.27, 0.75)
Heart rate (beats/min)
79.28 (11.54)
79.25 (11.50)
79.40 (11.71)
− 0.15 (− 0.71, 0.40)
Educationa
 Level 1 (illiterate)
2202 (21.3)
1754 (21.3)
448 (21.4)
0.0086 (− 0.0119, 0.0289)
 Level 2 (< 9 years)
6000 (58.1)
4831 (58.6)
1169 (55.8)
 Level 3 (9–12 years)
1520 (14.7)
1203 (14.6)
317 (15.1)
 Level 4 (> 12 years)
611 (5.9)
450 (5.5)
161 (7.7)
Marital status
 Single
1814 (17.6)
1337 (16.2)
477 (22.8)
0.0759 (0.0540, 0.0979)
 Married
8149 (78.9)
6625 (80.4)
1524 (72.7)
 Divorced/widowed
370 (3.6)
276 (3.4)
94 (4.5)
FH-CVD in female relatives
840 (8.1)
669 (8.1)
171 (8.2)
− 0.0009 (− 0.0293, 0.0275)
FH-CVD in male relatives
843 (8.2)
657 (8.0)
186 (8.9)
− 0.019 (− 0.048, 0.009)
FHD in first-degree relatives
2801 (27.1)
2255 (27.4)
546 (26.1)
0.0107 (− 0.0066, 0.0280)
PAL
 Inactiveb
6827 (70.5)
5458 (70.7)
1369 (69.9)
− 0.0063 (− 0.0239, 0.0114)
Smoking
 Never
7684 (75.6)
6207 (76.5)
1477 (72.1)
− 0.0001 (− 0.0305, 0.0304)
 Past
702 (6.9)
567 (7.0)
135 (6.6)
 Current
1776 (17.5)
1339 (16.5)
437 (21.3)
Use of blood lipid lowering drugs
231 (2.2)
177 (2.1)
54 (2.6)
− 0.0317 (− 0.0869, 0.0234)
Use of blood glucose lowering drugs
320 (3.1)
234 (2.8)
86 (4.1)
− 0.0681 (− 0.1173, − 0.0189)
Use of anti hypertensive drugs
434 (4.2)
335 (4.1)
99 (4.7)
− 0.0265 (− 0.0667, 0.0138)
Use of aspirin
933 (9.0)
717 (8.7)
216 (10.3)
− 0.0316 (− 0.0599, -0.0034)
Use of diuretics
120 (1.2)
93 (1.1)
27 (1.3)
− 0.0225 (− 0.0976, 0.0526)
Prevalence CVD
324 (3.1)
219 (2.7)
105 (5.0)
− 0.1253 (− 0.1768, -0.0737)
Figures are either mean (SD) or n (%) for continuously and categorically distributed variables, respectively
TLGS Tehran Lipid and Glucose Study, BMI body mass index, FPG fasting plasma glucose, TG triglyceride, TC total cholesterol, HDL-C HDL cholesterol, eGFR estimated glomerular filtration rate, SBP systolic blood pressure, DBP diastolic blood pressure, FH-CVD family history of premature cardiovascular disease, FHD family history of diabetes mellitus, PAL physical activity level, CVD cardiovascular disease
aThe adjusted risk differences (95% CI) between followed and non-followed participants regarding categorical variables were estimated by logistic regression adjrr command in stata
bDoing exercise or labor less than three times a week or performing activities achieving < 600 metabolic equivalent of task (MET)
Table 3 shows baseline characteristics of the study participants with and without incident CKD. In both genders, the participants who developed incident CKD were older, had higher BMI, FPG, TG, TC, SBP, DBP, WC and wrist circumferences but lower heart rate and were more likely to be married compared with participants free of CKD. Moreover, frequency of taking lipid, blood glucose and blood pressure lowering drugs as well as aspirin was higher in incident cases of CKD compared to non CKD participants (p < 0.01 for all of these measures).
Table 3
Baseline characteristics of the study participants with and without incident CKD, Tehran Lipid and Glucose Study (1999–2014)
Variables
Men
Women
Non CKD
n = 3002
Incident CKD
n = 793
p-value
Non CKD
n = 2928
Incident CKD
n = 1515
p-value
Age (years)
39.1 (13.3)
50.3 (13.6)
< 0.001
34.2 (10.6)
43.8 (12.4)
< 0.001
Total length of stay in the city (years)
33.1 (12.5)
40.3 (14.1)
< 0.001
28.9 (11.7)
36.5 (13.59)
< 0.001
BMI (kg/m2)
25.7 (4.2)
26.3 (3.9)
< 0.001
26.6 (5.1)
28.1 (4.8)
< 0.001
Waist circumference (cm)
88.5 (11.5)
90.9 (11.1)
< 0.001
84.5 (12.7)
88.9 (12.5)
< 0.001
Wrist circumference (cm)
17.6 (0.9)
17.8 (0.9)
< 0.001
15.7 (1.1)
16.1 (1.1)
< 0.001
Hip circumference (cm)
96.6 (7.3)
97.1 (7.1)
0.086
102.8 (9.5)
104.6 (9.4)
< 0.001
FPG (mmol/l)
4.9 (4.7–5.5)
5.2 (4.8–5.7)
< 0.001
4.8 (4.5–5.2)
4.9 (4.7–5.5)
< 0.001
TG (mmol/l)
1.7(1.1–2.5)
1.8(1.3–2.6)
< 0.001
1.3(0.9–1.9)
1.6 (1.1–2.3)
< 0.001
TC (mmol/l)
5.1 (1.1)
5.3 (1.1)
< 0.001
5.1 (1.1)
5.5 (1.3)
< 0.001
HDL-C (mmol/l)
0.9 (0.2)
0.9 (0.2)
0.48
1.1 (0.3)
1.2 (0.3)
0.210
eGFR (mL/min/1.73 m2)
79.2(10.6)
69.2 (7.4)
< 0.001
77.1 (10.1)
68.8 (7.1)
< 0.001
SBP (mmHg)
117.1 (15.4)
125.2 (19.7)
< 0.001
111.8 (14.9)
120.1 (19.6)
< 0.001
DBP (mmHg)
76.3 (10.3)
80.1(11.6)
< 0.001
74.6 (10.1)
78.2 (10.8)
< 0.001
Heart rate (beats/min)
75.5 (9.8)
74.47 (10.1)
0.015
83.5(11.8)
81.1 (11.4)
< 0.001
Education
 Level 1 (illiterate)
518 (17.3)
221 (27.9)
 
560 (19.1)
455 (30.0)
 
 Level 2 (< 9 years)
1858 (61.9)
370 (46.7)
< 0.001
1884 (64.3)
719 (47.5)
< 0.001
 Level 3 (9–12 years)
528 (17.6)
160 (20.2)
 
361 (12.3)
154 (10.2)
 
 Level 4 (> 12 years)
98 (3.3)
42 (5.3)
 
123 (4.2)
187 (12.3)
 
Marital status
 Single
686 (22.9)
57 (7.2)
 
503 (17.2)
91 (6.0)
 
 Married
2302 (76.7)
725 (91.4)
< 0.001
2325 (79.4)
1273 (84.0)
< 0.001
 Divorced/widowed
14 (0.5)
11 (1.4)
 
100 (3.4)
151 (10.0)
 
FH-CVD in female relatives
200 (6.7)
67 (8.4)
0.080
244 (8.3)
158 (10.4)
0.021
FH-CVD in male relatives
256 (8.5)
54 (6.8)
0.116
213 (7.3)
134 (8.8)
0.064
FHD in first-degree relatives
783 (26.1)
194 (24.5)
0.354
822 (28.1)
456 (30.1)
0.157
PAL
 Inactivea
2009 (71.2)
524 (69.4)
0.331
1908 (70.4)
1017 (70.9)
0.716
Smoking
 Never
1630 (55.1)
437 (56.2)
0.001
2747 (95.1)
1393 (93.6)
 
 Past
378 (12.8)
132 (17.0)
33 (1.1)
24 (1.6)
0.101
 Current
950 (32.1)
208 (26.8)
109 (3.8)
72 (4.8)
 
Use of blood lipid lowering drugs
41 (1.4)
22 (2.8)
0.006
49 (1.7)
65 (4.3)
< 0.001
Use of blood glucose lowering drugs
55 (1.8)
45 (5.7)
< 0.001
54 (1.8)
80 (5.3)
< 0.001
Use of anti hypertensive drugs
59 (2.0)
54 (6.8)
< 0.001
90 (3.1)
132 (8.7)
< 0.001
Use of aspirin
286 (9.5)
108 (13.6)
0.001
172 (5.9)
151 (10.0)
< 0.001
Use of diuretics
12 (0.4)
10 (1.3)
0.004
37 (1.3)
34 (2.2)
0.013
Prevalence CVD
87 (2.9)
53 (6.7)
< 0.001
30 (1.0)
49 (3.2)
< 0.001
Figures are either mean (SD) or N (%) for continuously and categorically distributed variables, respectively
TLGS Tehran Lipid and Glucose Study, BMI body mass index, FPG fasting plasma glucose, TG triglyceride, TC total cholesterol, HDL-C HDL cholesterol, eGFR estimated glomerular filtration rate, SBP systolic blood pressure, DBP diastolic blood pressure, FH-CVD family history of premature cardiovascular disease, FHD family history of diabetes mellitus, PAL physical activity level, CVD cardiovascular disease
aDoing exercise or labor less than three times a week or performing activities achieving < 600 metabolic equivalent of task (MET)
Overall, 2308 new cases of CKD (men = 793 and women = 1515) were identified after a median follow-up of 12.4 [interquartile range (IQR), 9.8–13.6] years. Among incident cases of CKD, 2294 subjects developed stage 3 CKD (eGFR 30–59 ml/min/1.73 m2), 12 cases developed stage 4 CKD (eGFR 15–29 ml/min/1.73 m2), and 2 cases developed stage 5 CKD (eGFR < 15 ml/min/1.73 m2). The incidence density rates of CKD were 20.2 (95% CI 18.8–21.7) and 35.2 (33.5–37.1) per 1000 person-years in men and women, respectively. Figure 2 depicts the survival curve for men and women. Survival of women was lower than that of men during study period (Log-Rank χ2 176, p < 0.001). From the 8238 baseline population, 269 (men = 196) cases of mortality were documented during the study period; of these, 119 (men = 93) cases died from CVD.

Predictors of incident CKD in men according to Cox model

Among men, age, FPG and DBP were positively associated with the risk of CKD (Table 4). In contrast, WC and TC were negatively associated with the risk of CKD. Also, an inverse association between eGFR and CKD was found in men; every 1-unit increase in eGFR was associated with a 10% reduction in the risk of CKD (HR 0.90; 95% CI 0.89–0.91). The HR for CKD among men with higher education (> 12 years) was 1.56 (1.06–2.28) compared to illiterate group. Being divorced/widower increased the risk of CKD by 204% (1.09–3.84) compared with being married. Interestingly, active men had 21% (1.03–1.42) higher risk of CKD compared to the inactive group. Current smoking was associated with a 24% (1.03–1.48) increase in the risk of CKD. The use of blood glucose lowering drugs at study entry was associated with 59% (1.08–2.35) higher risk of CKD.
Table 4
Multivariate Cox regression analysis of factors associated with CKD incidence by gender, Tehran Lipid and Glucose Study (1999–2014)
Variables
HRs
95% Confidence interval
p-value
Men
 Age (years)
1.04
1.03–1.05
< 0.001
 eGFR (ml/min/1.73 m2)
0.90
0.89–0.91
< 0.001
 FPG (mmol/l)
1.10
1.05–1.16
< 0.001
 DBP (mmHg)
1.02
1.01–1.03
< 0.001
 TC (mmol/l)
0.89
0.83–0.96
0.0025
 Waist circumference (cm)
0.98
0.97–0.99
0.016
 Hip circumference (cm)
1.02
1.00–1.03
0.075
 Heart rate (beats/min)
0.99
0.99–1.00
0.093
 Education
  Level 1 (illiterate)
Reference
  
  Level 2 (< 9 years)
1.18
0.83–1.67
0.34
  Level 3 (9–12 years)
1.24
0.87–1.78
0.23
  Level 4 (> 12 years)
1.56
1.06–2.28
0.021
 Marital status
  Married
Reference
  
  Single
1.06
0.77–1.47
0.70
  Divorced/widowed
2.04
1.09–3.84
0.025
 FH–CVD in female relatives
  No
Reference
  
  Yes
1.25
0.97–1.62
0.080
 PAL
  Inactivea
Reference
  
  Active
1.21
1.03–1.42
0.016
 Smoking
  Never
Reference
  
  Past
1.06
0.87–1.30
0.51
  Current
1.24
1.03–1.48
0.017
 Use of blood glucose lowering drugs
  No
Reference
  
  Yes
1.59
1.08–2.35
0.017
 Use of aspirin
  No
Reference
  
  Yes
0.84
0.67–1.04
0.116
Women
 Age (years)
1.02
1.02–1.03
< 0.001
 eGFR (mL/min/10.73 m2)
0.91
0.91–0.92
< 0.001
 FPG (mmol/L)
1.05
1.02–1.08
< 0.001
 Heart rate (beats/min)
0.99
0.98–0.99
< 0.001
 Waist circumference (cm)
0.99
0.98–0.99
0.002
 SBP (mmHg)
1.01
1.00–1.01
0.028
 Wrist circumference (cm)
1.05
1.00–1.01
0.119
 FHD in first-degree relatives
  No
Reference
  
  Yes
0.90
0.79–1.01
0.08
 Prevalence CVD
  No
Reference
  
  Yes
1.35
0.99–1.82
0.048
The Stepwise Cox PH regression model using AIC as model selection approach was used to identify significant predictors of incident CKD by calculating multivariable hazard ratios (HRs) with 95% CI
TLGS Tehran Lipid and Glucose Study, PH proportional hazard, AIC Akaike information criteria, TLGS Tehran Lipid and Glucose Study, FPG fasting plasma glucose, TC total cholesterol, eGFR estimated glomerular filtration rate, SBP systolic blood pressure, DBP diastolic blood pressure, FH-CVD family history of premature cardiovascular disease, FHD family history of diabetes mellitus, PAL physical activity level, CVD cardiovascular disease
aDoing exercise or labor less than three times a week or performing activities achieving < 600 metabolic equivalent of task (MET)

Predictors of incident CKD in women according to Cox model

The associations of age, FPG and WC with incidence of CKD in women were similar to those observed for men (Table 4). Every 1-unit increase in eGFR was associated with a 9% reduction in the risk of CKD (HR 0.91; 0.91–0.92). Additionally, SBP and heart rate were significantly associated with CKD incidence. Prevalent CVD at baseline was associated with a 35% (0.99–1.82) increase in the risk of CKD.

Predictors of incident CKD in whole population according to Cox model

In the whole population, women had more than double risk (HR 2.09; 1.82–2.39) of CKD compared with men. Moreover, age, FPG, and DBP were positively associated with CKD incidence. In contrast, eGFR, WC, TC and heart rate were negatively associated with the risk of CKD. Every 1-unit increase in eGFR was associated with a 9% reduction in the risk of CKD (HR 0.91; 0.90–0.92). Prevalent CVD at baseline was associated with a 25% (1.01–1.54) increase in the risk of CKD. The HR for CKD among individuals with higher education (> 12 years) was 1.41 (1.14–1.72) compared to illiterate individuals (Table 5).
Table 5
Multivariate Cox regression analysis of factors associated with CKD incidence in total population, Tehran Lipid and Glucose Study (1999–2014)
Variables
HR
95% CI
p-value
Gender
 Male
Reference
  
 Female
2.09
1.82–2.39
< 0.001
Age (years)
1.03
1.02–1.03
< 0.001
eGFR (ml/min/1.73 m2)
0.91
0.90–0.92
< 0.001
Waist circumference (cm)
0.99
0.98–0.99
< 0.001
FPG (mmol/l)
1.06
1.03–1.09
< 0.001
Heart rate (beats/min)
0.99
0.98–0.99
< 0.001
TC (mmol/l)
0.95
0.91–0.99
0.043
DBP (mmHg)
1.01
1.00–1.01
0.045
SBP (mmHg)
1.00
0.99–1.00
0.056
Wrist circumference (cm)
1.05
0.99–1.10
0.077
Education
 Level 1 (illiterate)
Reference
  
 Level 2 (< 9 years)
1.05
0.89–1.24
0.541
 Level 3 (9–12 years)
1.11
0.92–1.33
0.255
 Level 4 (> 12 years)
1.41
1.14–1.72
0.001
Marital status
 Married
Reference
  
 Single
0.90
0.74–1.09
0.312
 Divorced/widowed
1.19
0.99–1.42
0.057
FHD in first-degree relatives
 No
Reference
  
 Yes
0.90
0.82–0.99
0.045
Use of blood glucose lowering drugs
 No
Reference
  
 Yes
1.22
0.96–1.56
0.097
PAL
 Inactivea
Reference
  
 Active
1.09
0.99–1.20
0.064
Prevalence CVD
 No
Reference
  
 Yes
1.25
1.01–1.54
0.035
The Stepwise Cox PH regression model using AIC as model selection approach was used to identify significant predictors of incident CKD by calculating multivariable hazard ratios (HRs) with 95% CI
TLGS Tehran Lipid and Glucose Study, PH proportional hazard, CI confidence interval, AIC Akaike information criteria, FPG fasting plasma glucose, TC total cholesterol, eGFR estimated glomerular filtration rate, SBP systolic blood pressure, DBP diastolic blood pressure, FHD family history of diabetes mellitus, PAL physical activity level, CVD cardiovascular disease
aDoing exercise or labor less than three times a week or performing activities achieving < 600 metabolic equivalent of task (MET)

Survival tree in men

The results of the survival tree in men are presented in Fig. 3. The eGFR, age, FPG, PAL and WC were selected by the tree to group the male population. The best cutoff values for these predictors were found by the survival tree algorithm. The eGFR was found as the most important predictor for CKD with a cutoff value of 69.8 ml/min/1.73 m2. The group with eGFR ≤ 69.8 ml/min/1.73 m2 (left side of the tree) was further split by age; so that, the group with eGFR < 63.4 ml/min/1.73 m2 and age > 50 year had the highest risk for CKD. The lowest risk was found among younger men aged ≤ 46 year and eGFR > 74 ml/min/1.73 m2. A moderate risk was explored among the groups with eGFR > 69.85 ml/min/1.73 m2 and age > 46 year; survival probability among these groups depended on the SBP and FPG. So that, the group with SBP > 119 mmHg and FPG > 5.8 mmol/l had the lowest survival. Ultimately, 12 groups were identified by the survival tree algorithm. The Kaplan–Meier curves for these groups are shown in Fig. 4a. The curves of nodes 4, 5, 7, 8, 22 and 23 were lower than the whole population’s curve, showing that they covered high risk groups for the CKD events among men. The symmetric remark can be made for nodes (11, 15, 16, 17, 18 and 20) which had a survival probability above the whole population’s curve which covered low risk groups for the CKD events in men. Using node 15 with the lowest risk as the reference group, HRs of CKD was estimated for all other groups (nodes). Accordingly, node 5 had the highest risk for CKD incidence, compared to node 15 (HR 70.6; 34.6–144.5; p < 0.001) (Table 6).
Table 6
Cox analyses of patterns identified using survival tree in the male population, Tehran Lipid and Glucose Study (1999–2014)
Nodes
Number of cases/number of events
Pattern description
HRs (95% CI)
p-value
15
331/8
eGFR > 74 ml/min/1.73 m2, age ≤ 46 year, PAL < 600 MET, WC ≤ 100 cm, FPG ≤ 4.7 mmol/l
Reference
4
110/58
eGFR ≤ 63.4 ml/min/1.73 m2, age ≤ 50 year
34.67 (16.54–72.65)
< 0.001
5
192/130
eGFR ≤ 63.4 ml/min/1.73 m2, age > 50 year
70.68 (34.57–144.52)
< 0.001
7
432/130
63.4 < eGFR ≤ 74 ml/min/1.73 m2, age ≤ 50 year
14.91 (7.30–30.45)
< 0.001
8
365/172
63.4 < eGFR ≤ 74 ml/min/1.73 m2, age > 50 year
35.82 (17.61–72.85)
< 0.001
11
368/62
70 < eGFR ≤ 74 ml/min/1.73 m2, age ≤ 46 year
7.48 (3.58–15.62)
< 0.001
16
771/39
eGFR > 74 ml/min/1.73 m2, age ≤ 46 year, PAL < 600 MET, WC ≤ 100 cm, FPG > 4.7 mmol/l
2.16 (1.01–4.63)
< 0.05
17
143/14
eGFR > 74 ml/min/1.73 m2, age ≤ 46 year, PAL < 600 MET, WC > 100 cm
4.67 (1.95–11.13)
< 0.001
18
481/27
eGFR > 74 ml/min/1.73 m2, age ≤ 46 year, PAL ≥ 600 MET
3.02 (1.37–6.67)
< 0.001
20
237/37
eGFR > 70 ml/min/1.73 m2, age > 46 year, SBP ≤ 119 mmHg
8.63 (4.02–18.55)
< 0.001
22
262/75
eGFR > 70 ml/min/1.73 m2, age > 46 year, SBP > 119 mmHg, FPG ≤ 5.8 mmol/l
15.47 (7.46–32.08)
< 0.001
23
103/41
eGFR > 70 ml/min/1.73 m2, age > 46 year, SBP > 119 mmHg, FPG > 5.8 mmol/l
27.26 (12.77–58.18)
< 0.001
Column 1 shows the number of terminal nodes of survival tree of Fig. 3 for male population. Column 2 displays the sample size and number of events in each terminal node. Column 3 represents the patterns of each terminal node. Column 4 shows the HR for each node compared to node with high survival probability as the reference node
CI Confidence intervals, HRs Hazard ratio, SBP Systolic blood pressure, eGFR Estimated glomerular filtration rate, FPG Fasting plasma glucose, PAL Physical activity level, WC Waist circumference, MET Metabolic equivalent of task

Survival tree in women

The survival tree for women is shown in Fig. 5. Three variables (age, eGFR and SBP) were found as the most significant predictors associated with CKD. Initially, the participants were split by age with the cutoff value of 45 year (p < 0.001). On the right side of the tree, the group aged > 45 year was split by eGFR with a cutoff value of 69.35 ml/min/1.73 m2; then, the group with eGFR > 69.35 ml/min/1.73 m2 was split by SBP with a cutoff value of 133 mmHg. Further inspection of the tree showed that in age > 45 year, a SBP > 133 mmHg can significantly increase the risk of CKD. Among women in younger age (< 45 year), those with eGFR > 83.5 ml/min/1.73 m2 (node 12) and eGFR < 65 ml/min/1.73 m2 (node 4) had the lowest and highest risk, respectively, for incidence of CKD. The Kaplan–Meier curves for the ten groups are shown in Fig. 4b. The survival curves of nodes 16, 4, 19, 15, and 7 were lower than the whole population’s curve, and survival curves of nodes 12, 11, 6, and 9 had a survival probability above the whole population’s curve, showing the high risk and low risk groups for the CKD events among women, respectively. As Table 7 shows, node 16 had the highest risk for CKD incidence, compared to node 12 as the reference group (HR 27.25; 19.88–37.34; p < 0.001).
Table 7
Cox analyses of patterns identified using survival tree in the female population, Tehran Lipid and Glucose Study (1999–2014)
Nodes
Number of cases/number of events
Pattern description
HRs (95% CI)
p-value
12
750/43
Age ≤ 45 year, eGFR > 83.5 ml/min/1.73 m2
Reference
4
419/247
Age ≤ 45 year, eGFR ≤ 65 ml/min/1.73 m2
15.18 (10.97–20.99)
< 0.001
6
157/41
Age ≤ 29 year, 65 ≤ eGFR ≤ 71 ml/min/1.73 m2
5.07 (3.30–7.77)
< 0.001
7
549/220
29 ≤ Age ≤ 45 year, 65 ≤ eGFR ≤ 71 ml/min/1.73 m2
8.78 (6.32–12.15)
< 0.001
9
656/166
Age ≤ 45 year, 71 ≤ eGFR ≤ 76 ml/min/1.73 m2
4.93 (3.52–6.90)
< 0.001
11
799/124
Age ≤ 45 year, 75 ≤ eGFR ≤ 83.5 ml/min/1.73 m2
2.72 (1.92–3.86)
< 0.001
15
152/74
45 ≤ Age < 48 year, eGFR ≤ 69 ml/min/1.73 m2
12.06 (8.28–17.57)
< 0.001
16
580/423
Age > 48 year, eGFR ≤ 69 ml/min/1.73 m2
27.25 (19.88–37.34)
< 0.001
18
241/97
Age > 45 year, eGFR > 69 ml/min/1.73 m2, SBP ≤ 133 mmHg
8.95 (6.25–12.82)
< 0.001
19
140/80
Age > 45 year, eGFR > 69 ml/min/1.73 m2, SBP > 133 mmHg
16.41(11.32–23.80)
< 0.001
Column 1 shows the number of terminal nodes of survival tree of Fig. 5 for female population. Column 2 displays the sample size and number of events in each terminal node. Column 3 represents the patterns of each terminal node. Column 4 shows the HR for each node compared to reference node with high survival probability
CI Confidence intervals, HRs Hazard ratio, SBP Systolic blood pressure, eGFR Estimated glomerular filtration rate

Discussion

The results of the present study showed that more than 20 and 35% of men and of women, respectively, developed CKD during 15 years follow-up. Results of the multivariate Cox PH models showed that women had more than double risk for CKD incidence compared to men. The eGFR, age, FPG and WC were significant predictors for incident CKD in both genders and whole population. However, in men, DBP, TC, current smoking, being divorced/widower, higher educational levels (> 12 year), taking blood glucose lowering drugs and PAL were significantly associated with an increased risk of CKD. In women, it was found that SBP, heart rate and prevalent CVD were significantly associated with CKD in addition to the four common predictors.
Compared to other population-based studies in the US, Europe and Japan [30], the incidence rate of CKD was higher in our study, despite the lower mean age of the population. The higher incidence of CKD in our study population could be due to life style changes, leading to a sharp rise in risk factors of chronic diseases [31]. In line with our previous study [32], we found female gender and aging as an independent factor associated with CKD, as reported by other studies [30, 33].
Interestingly, Cox models showed that higher WC was associated with lower risks of CKD among both genders. Some studies have shown that a higher WC was associated with the lower risk of CKD [32]; while a number of studies reported no significant association [34]. Surprisingly, we found a negative association between TC and incident CKD in men and whole population. The association between CKD and dyslipidemia has not been demonstrated in prospective studies, and is still subject to controversy [35, 36].
Hypertension is recognized as a strong predictor for progression of renal dysfunction [32]. We found a positive and significant relationship between hypertension and CKD in both genders and whole population. In line with other studies [37], we showed a positive association between FPG and incidence of CKD in both genders and whole population. In the present study, among whole population and men, individuals with high educational levels (> 12 years of education), showed increased risk for CKD compared to illiterates. In our previous study, a similar association was found in women [32]. However, inverse association has been reported in other cross sectional and prospective studies [38]. The positive association between high educational levels and incident CKD observed in our study may be attributed to the direct and indirect impact of higher education on higher income. Since high income is almost coincides with high fat, protein and salt consumption, it affects the incident CKD through increasing prevalence of some chronic disease such as hypertension, diabetes, and obesity [39]. Further investigations are needed in order to better clarify this relationships.
Smoking is known as an independent risk factor for progression to CKD [37, 40]. Our study also showed that current smokers had increased risk of CKD compared to never smokers only in men.
To date, studies assessing the association between physical activity and CKD incidence have provided conflicting results [41]. Surprisingly, we found 21% higher risk of CKD in “active” men.
We found significant association between elevated heart rate and lower risks of CKD incidence among women and whole population. This association is contrary to the results of Brotman [42], who reported an association between higher resting heart rate and CKD incidence. As heart rate is affected by many interior and exterior factors, more studies are needed to explain this unexpected result.
Compared with the general population, patients with CKD have an unacceptably higher risk for premature death, primarily as a result of CVD [43]. In our study, prevalent CVD at baseline was associated with risk of developing CKD among women and whole population.

Interaction patterns identified by the survival trees

According to survival tree analysis, eGFR and age were found as the most important predictors for CKD incidence among men and women, respectively. Current evidences from cross sectional and longitudinal studies suggest that decline in GFR is a universal phenomenon which happens after age 30 in both men and women, and the rate of decline accelerates after age 50–60 years [44]. This decline appears to be a part of the normal physiologic process and is associated with structural changes in the kidney [45].
Survival tree in woman (Fig. 5) shows that not only aging is the most important predictor for CKD progression, but suggesting that the critical threshold of age for developing CKD is much lower than 30. As Fig. 5 shows, a group of women with age ≤ 29 year and eGFR between 65 and 71 ml/min/1.73 m2 had a moderate risk of developing CKD during the follow-up period (node 6).
According to our findings, the lowest risk was found among women aged ≤ 45 year and with eGFR > 83 ml/min/1.73 m2; suggesting that the threshold of ≥ 83 ml/min/1.73 m2 for eGFR is a safe value for decreasing the risk of CKD among women aged ≤ 45 year.
Figure 5 also shows that among women aged > 45 year, a SBP > 133 mmHg (high-range pre-hypertension and hypertension) was significantly associated with increased risk of CKD even with eGFR > 69 ml/min/1.73 m2. According to a recent study, the overall prevalence of prehypertension was approximately 46% among adult Iranian population [46]; therefore, the effective strategies for the prevention and treatment of prehypertension is required to be considered among Iranian women.
Overall, the survival tree in women found 10 prognostic groups, defined only by the age, eGFR and SBP; it does not mean that other variables have no predictive ability in the CKD incidence. If the tree is growing in full depth, other variables may be involved in the prediction of CKD; however, the number of subjects in the terminal nodes will be so small for significant results.
Survival tree in male population identified 12 subgroups with different patterns (Fig. 3). The highest risk was found among men with eGFR < 63 ml/min/1.73 m2 (nodes 4 and 5).
As we previously mentioned, the Cox PH model found negative association between WC and PAL in relation to risk of CKD among male population (Table 4). These unexpected results may be explained by the interactions found by the survival tree; as the Fig. 3 shows, low PAL and WC > 100 cm was significantly associated with increased risk of CKD (node 17); while, WC < 100 cm and FPG ≤ 4.7 mmol/l improved survival rate among inactive men (node 15). These findings suggest that there is a particularly strong interaction between these factors in relation to CKD incidence among male population. Survival tree also found a group of men aged > 46 year with a SBP > 119 mmHg (prehypertension and hypertension) and FPG > 5.83 mmol/l (pre-diabetes and diabetes), who had moderate risk of CKD incidence. In line with our findings, Yamagata et al. [37] showed that hypertension and diabetes were independent predictor for developing CKD. Because of the high prevalence and incidence of pre-hypertension, hypertension, pre-diabetes and diabetes among Iranian population [47], more attention should be paid to early intervention and risk factor modification for this high risk group.
In summary, survival trees are the helpful exploratory tools that have been applied in recent years in different medical studies [4851]. However, investigators should be aware of their drawbacks and limitations. A major issue with survival trees is that they can be built to fit the training data too perfectly (over fit); while it may not perform well on other unknown data [52]. We used the conditional inference survival tree developed by Hothorn et al. [53], which is shown to be more reliable and less likely to over fit compared to the other survival tree algorithms.
This study is subject to some limitations. First, our study was a post hoc analysis of a prospective cohort that was not able to control for some covariates related to CKD such as family history of kidney disease that is related to decline in kidney function beginning at early ages [54]. Additionally, no quantitative urinary indexes were available at the baseline or follow-up visit, because, the cohort was not originally designed for kidney diseases. Second, this study has been conducted on a sample of Iranian population and further studies should be conducted to determine whether our findings could be applicable to other populations. Third, as inherent to any prospective cohort study, the level of risk factors at the baseline examination might change during the follow up, e.g. some degree of misclassification may have occurred in this study, leading to biased estimated hazard ratios towards the null. Fourth, about 20% of participants were lost to follow-up in our study; we found statistically but not clinically important differences between the followed vs. non-followed population in some baseline variables. In total population, mean values of FPG and eGFR were lower, and TC and WC were higher in followed compared to non-followed population. Since FPG and eGFR were reported to be the most important predictors for CKD among Iranian population [32], we may underestimate the incidence of CKD in our study. To evaluate the extent to which lost to follow-up may have influenced measures of association in final models, we calculated propensity scores in both genders and in the total population. The PS is the conditional probability that an individual participate in the follow-up, given a set of covariates [55]. To obtain PS, we applied multivariable logistic regression with participation in the follow-up as the outcome and all baseline variables as the predictors. The estimated probability of participation, or the PS, derived from the multivariable logistic regression model described above was added to the final Cox PH models. In general, in both genders and total population, there were no changes in estimated HRs and CIs for predictors in the Cox PH models. We also added PS as a covariate to develop survival tree models along with all baseline covariates; interestingly, adding the PS did not alter the structure of survival tree in both genders and total population (data not shown). Therefore, lost to follow-up did not cause selection bias in our study. And last but not least, our diagnosis of CKD was based on a single estimate of GFR, which we acknowledge tends to overestimate the incidence of kidney disease [37].
As strengths, this is the first study that identified interactions between CKD risk factors in a well-characterized cohort of adults using the survival tree approach. We used data from a large, long-term, population-based cohort of men and women. In fact, in men, the statistical power of our study to detect a HR of 20, 30 and 50% for incident CKD was 72, 95 and 99%; the corresponding values in women were 94, 99 and 100%, respectively. We assessed the actual measurement of blood pressure and laboratory parameters, rather than self-reported data. In addition, we investigated a wide range of variables as potential predictors.
As, there will never be enough resources to implement every programme for all population, health policy makers prefer interventions that target high-risk groups [56]. Our study, identified not only risk factors of CKD in total population by Cox model but also identified high-risk groups by survival tree analysis, which can be used for implement specific interventions for each group according their level of risk.

Conclusions

Cox regression models is suitable for demonstrating the relation of a predictor to the outcome; while, survival trees are ideally suited for exploration of some prognostic groups of individuals by detecting certain types of interactions without the need to specify them beforehand. In our study, Cox PH models identified the main effects of the several traditional risk factors of CKD; however, survival tree analysis identified a number of interactions between those risk factors. Survival trees created 12 subgroups with different patterns of eGFR, age, FPG, physical activity level and WC in men. Among women, age, eGFR and SBP interacted with each other and identified 10 subgroups. In conclusion, these two statistical methods can be deemed to be somewhat complementary for survival data analysis. The prognostic groups could potentially be valuable for early detection and management of high risk individuals for CKD in the public health setting and at clinic.

Authors’ contributions

AR analyzed data and wrote the manuscript. MT participated in the interpretation of results. FA and FH, designed the study protocol, and participated in the coordination and management of the study. All authors read and approved the final manuscript.

Acknowledgements

We express our appreciation to the participants of district-13 of Tehran for their enthusiastic support in this study.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All datasets generated and analyzed during the current study are available from the corresponding author upon reasonable request.
Not applicable.
Protocol of this study was approved by the ethical committee of the Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences, Tehran, Iran, and conducted in accordance with the Declaration of Helsinki. All participants signed informed consent forms.

Funding

This study was supported by Grant No. 121 from the National Research Council of the Islamic Republic of Iran.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72.CrossRefPubMed Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72.CrossRefPubMed
2.
Zurück zum Zitat Tsai W-C, Wu H-Y, Peng Y-S, Ko M-J, Wu M-S, Hung K-Y, et al. Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis. Medicine. 2016;95(11):e3013.CrossRefPubMedPubMedCentral Tsai W-C, Wu H-Y, Peng Y-S, Ko M-J, Wu M-S, Hung K-Y, et al. Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis. Medicine. 2016;95(11):e3013.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Ramirez-Rubio O, McClean MD, Amador JJ, Brooks DR. An epidemic of chronic kidney disease in Central America: an overview. Postgrad Med J. 2013;89(1049):123–5.CrossRefPubMed Ramirez-Rubio O, McClean MD, Amador JJ, Brooks DR. An epidemic of chronic kidney disease in Central America: an overview. Postgrad Med J. 2013;89(1049):123–5.CrossRefPubMed
4.
Zurück zum Zitat Radhakrishnan J, Remuzzi G, Saran R, Williams DE, Rios-Burrows N, Powe N, et al. Taming the chronic kidney disease epidemic: a global view of surveillance efforts. Kidney Int. 2014;86(2):246–50.CrossRefPubMedPubMedCentral Radhakrishnan J, Remuzzi G, Saran R, Williams DE, Rios-Burrows N, Powe N, et al. Taming the chronic kidney disease epidemic: a global view of surveillance efforts. Kidney Int. 2014;86(2):246–50.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Mangione F, Canton AD. The epidemic of chronic kidney disease: looking at ageing and cardiovascular disease through kidney-shaped lenses. J Intern Med. 2010;268(5):449–55.CrossRefPubMed Mangione F, Canton AD. The epidemic of chronic kidney disease: looking at ageing and cardiovascular disease through kidney-shaped lenses. J Intern Med. 2010;268(5):449–55.CrossRefPubMed
6.
Zurück zum Zitat Herget-Rosenthal S, Dehnen D, Kribben A, Quellmann T. Progressive chronic kidney disease in primary care: modifiable risk factors and predictive model. Prev Med. 2013;57(4):357–62.CrossRefPubMed Herget-Rosenthal S, Dehnen D, Kribben A, Quellmann T. Progressive chronic kidney disease in primary care: modifiable risk factors and predictive model. Prev Med. 2013;57(4):357–62.CrossRefPubMed
7.
Zurück zum Zitat McClellan WM, Ramirez SP, Jurkovitz C. Screening for chronic kidney disease: unresolved issues. J Am Soc Nephrol. 2003;14(suppl 2):81–7.CrossRef McClellan WM, Ramirez SP, Jurkovitz C. Screening for chronic kidney disease: unresolved issues. J Am Soc Nephrol. 2003;14(suppl 2):81–7.CrossRef
8.
Zurück zum Zitat Johnson RA, Wichern DW. Applied multivariate statistical analysis. Upper Saddle River: Prentice hall; 2002. Johnson RA, Wichern DW. Applied multivariate statistical analysis. Upper Saddle River: Prentice hall; 2002.
9.
Zurück zum Zitat Kleinbaum DG, Klein M. Logistic regression: a self-learning text. 3rd ed. New York: Springer; 2010.CrossRef Kleinbaum DG, Klein M. Logistic regression: a self-learning text. 3rd ed. New York: Springer; 2010.CrossRef
10.
Zurück zum Zitat Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med. 2015;13(1):1.CrossRefPubMedPubMedCentral Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med. 2015;13(1):1.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Zhang H, Singer B. Recursive partitioning and applications. Berlin: Springer Science & Business Media; 2010.CrossRef Zhang H, Singer B. Recursive partitioning and applications. Berlin: Springer Science & Business Media; 2010.CrossRef
12.
Zurück zum Zitat Su S-L, Lin C, Kao S, et al. Risk factors and their interaction on chronic kidney disease: a multi-centre case control study in Taiwan. BMC Nephrol. 2015;16(16):83.CrossRefPubMedPubMedCentral Su S-L, Lin C, Kao S, et al. Risk factors and their interaction on chronic kidney disease: a multi-centre case control study in Taiwan. BMC Nephrol. 2015;16(16):83.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Liu W-C, Hung C-C, Chen S-C, et al. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol. 2012;7(4):541–8.CrossRefPubMed Liu W-C, Hung C-C, Chen S-C, et al. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol. 2012;7(4):541–8.CrossRefPubMed
14.
Zurück zum Zitat Loh WY. Fifty years of classification and regression trees. Int Stat Rev. 2014;82(3):329–48.CrossRef Loh WY. Fifty years of classification and regression trees. Int Stat Rev. 2014;82(3):329–48.CrossRef
15.
Zurück zum Zitat Ramezankhani A, Pournik O, Shahrabi J, Khalili D, Azizi F, Hadaegh F. Applying decision tree for identification of a low risk population for type 2 diabetes. Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2014;105(3):391–8.CrossRefPubMed Ramezankhani A, Pournik O, Shahrabi J, Khalili D, Azizi F, Hadaegh F. Applying decision tree for identification of a low risk population for type 2 diabetes. Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2014;105(3):391–8.CrossRefPubMed
18.
Zurück zum Zitat Parizadeh D, Ramezankhani A, Momenan AA, Azizi F, Hadaegh F. Exploring risk patterns for incident ischemic stroke during more than a decade of follow-up: a survival tree analysis. Comput Methods Programs Biomed. 2017;147:29–36.CrossRefPubMed Parizadeh D, Ramezankhani A, Momenan AA, Azizi F, Hadaegh F. Exploring risk patterns for incident ischemic stroke during more than a decade of follow-up: a survival tree analysis. Comput Methods Programs Biomed. 2017;147:29–36.CrossRefPubMed
20.
Zurück zum Zitat Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5.CrossRefPubMedPubMedCentral Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009;9:44.CrossRefPubMedPubMedCentral Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009;9:44.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Ainsworth BE, Jacobs DR Jr, Leon AS. Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc. 1993;25(1):92–8.CrossRefPubMed Ainsworth BE, Jacobs DR Jr, Leon AS. Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc. 1993;25(1):92–8.CrossRefPubMed
23.
Zurück zum Zitat Mirmiran Mohammadi, Allahverdian Azizi. Estimation of energy requirements for adults: Tehran Lipid and Glucose Study. Int J Vitam Nutr Res. 2003;73(3):193–200.CrossRefPubMed Mirmiran Mohammadi, Allahverdian Azizi. Estimation of energy requirements for adults: Tehran Lipid and Glucose Study. Int J Vitam Nutr Res. 2003;73(3):193–200.CrossRefPubMed
24.
25.
Zurück zum Zitat Momenan AA, Delshad M, Sarbazi N, Rezaei Ghaleh N, Ghanbarian A, Azizi F. Reliability and validity of the modifiable activity questionnaire (MAQ) in an Iranian urban adult population. Arch Iran Med. 2012;15(5):279–82.PubMed Momenan AA, Delshad M, Sarbazi N, Rezaei Ghaleh N, Ghanbarian A, Azizi F. Reliability and validity of the modifiable activity questionnaire (MAQ) in an Iranian urban adult population. Arch Iran Med. 2012;15(5):279–82.PubMed
26.
Zurück zum Zitat Levey ASEK, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100.CrossRefPubMed Levey ASEK, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100.CrossRefPubMed
27.
Zurück zum Zitat World Health Organization. Guidelines for controlling and monitoring the tobacco epidemic. Geneva: World Health Organization; 1998. World Health Organization. Guidelines for controlling and monitoring the tobacco epidemic. Geneva: World Health Organization; 1998.
28.
Zurück zum Zitat Jeon CY, Lokken RP, Hu FB, Van Dam RM. Physical activity of moderate intensity and risk of type 2 diabetes a systematic review. Diabetes Care. 2007;30(3):744–52.CrossRefPubMed Jeon CY, Lokken RP, Hu FB, Van Dam RM. Physical activity of moderate intensity and risk of type 2 diabetes a systematic review. Diabetes Care. 2007;30(3):744–52.CrossRefPubMed
29.
Zurück zum Zitat Hothorn T, Everitt BS. A handbook of statistical analyses using R. Boca Raton: CRC Press; 2014. Hothorn T, Everitt BS. A handbook of statistical analyses using R. Boca Raton: CRC Press; 2014.
30.
Zurück zum Zitat Hippisley-Cox J, Coupland C. Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney® Scores. BMC Fam Pract. 2010;11:49.CrossRefPubMedPubMedCentral Hippisley-Cox J, Coupland C. Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney® Scores. BMC Fam Pract. 2010;11:49.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Harati H, Hadaegh F, Saadat N, Azizi F. Population-based incidence of type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health. 2009;9:186.CrossRefPubMedPubMedCentral Harati H, Hadaegh F, Saadat N, Azizi F. Population-based incidence of type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health. 2009;9:186.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13(6):621–30.CrossRefPubMed Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13(6):621–30.CrossRefPubMed
34.
Zurück zum Zitat Lucove J, Vupputuri S, Heiss G, North K, Russell M. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis. 2008;51(1):21–8.CrossRefPubMed Lucove J, Vupputuri S, Heiss G, North K, Russell M. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis. 2008;51(1):21–8.CrossRefPubMed
35.
Zurück zum Zitat Schaeffner ES, Kurth T, Curhan GC, et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14(8):2084–91.PubMed Schaeffner ES, Kurth T, Curhan GC, et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14(8):2084–91.PubMed
36.
Zurück zum Zitat Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291(7):844–50.CrossRefPubMed Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291(7):844–50.CrossRefPubMed
37.
Zurück zum Zitat Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71(2):159–66.CrossRefPubMed Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71(2):159–66.CrossRefPubMed
38.
Zurück zum Zitat Hossain MP, Goyder EC, Rigby JE, El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis. 2009;53(1):166–74.CrossRefPubMed Hossain MP, Goyder EC, Rigby JE, El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis. 2009;53(1):166–74.CrossRefPubMed
39.
Zurück zum Zitat World Health Organization. Population nutrient intake goals for preventing diet-related chronic diseases. Geneva: World Health Organization; 2003. World Health Organization. Population nutrient intake goals for preventing diet-related chronic diseases. Geneva: World Health Organization; 2003.
40.
Zurück zum Zitat Xia J, Wang L, Ma Z, Zhong L, Wang Y, Gao Y, et al. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant. 2017;32(3):475–87.CrossRefPubMed Xia J, Wang L, Ma Z, Zhong L, Wang Y, Gao Y, et al. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant. 2017;32(3):475–87.CrossRefPubMed
41.
Zurück zum Zitat Koba S. Physical activity and chronic kidney disease. J Atheroscler Thromb. 2016;23(4):395–6.CrossRefPubMed Koba S. Physical activity and chronic kidney disease. J Atheroscler Thromb. 2016;23(4):395–6.CrossRefPubMed
42.
Zurück zum Zitat Brotman DJ, Bash LD, Qayyum R, et al. Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol. 2010;21(9):1560–70.CrossRefPubMedPubMedCentral Brotman DJ, Bash LD, Qayyum R, et al. Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol. 2010;21(9):1560–70.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008;3(2):505–21.CrossRefPubMed Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008;3(2):505–21.CrossRefPubMed
44.
Zurück zum Zitat Glassock RJ. Con: thresholds to define chronic kidney disease should not be age dependent. Nephrol Dial Transplant. 2014;29(4):774–9.CrossRefPubMed Glassock RJ. Con: thresholds to define chronic kidney disease should not be age dependent. Nephrol Dial Transplant. 2014;29(4):774–9.CrossRefPubMed
45.
Zurück zum Zitat Winearls DO. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. 2009;120:419–28.PubMedPubMedCentral Winearls DO. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. 2009;120:419–28.PubMedPubMedCentral
46.
Zurück zum Zitat Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, Shishehbor MH, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens. 2008;21(6):620–6.CrossRefPubMed Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, Shishehbor MH, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens. 2008;21(6):620–6.CrossRefPubMed
47.
Zurück zum Zitat Hadaegh F, Derakhshan A, Zafari N, Khalili D, Mirbolouk M, Saadat N, et al. Pre-diabetes tsunami: incidence rates and risk factors of pre-diabetes and its different phenotypes over 9 years of follow-up. Diabet Med. 2017;34(1):69–78.CrossRefPubMed Hadaegh F, Derakhshan A, Zafari N, Khalili D, Mirbolouk M, Saadat N, et al. Pre-diabetes tsunami: incidence rates and risk factors of pre-diabetes and its different phenotypes over 9 years of follow-up. Diabet Med. 2017;34(1):69–78.CrossRefPubMed
49.
Zurück zum Zitat Sawada S, Yamashita N, Suehisa H, Yamashita M. Risk factors for recurrence after lung cancer resection as estimated using the survival tree method. Chest. 2013;144(4):1238–44.CrossRefPubMed Sawada S, Yamashita N, Suehisa H, Yamashita M. Risk factors for recurrence after lung cancer resection as estimated using the survival tree method. Chest. 2013;144(4):1238–44.CrossRefPubMed
50.
Zurück zum Zitat Ali RA, Dooley C, Comber H, Newell J, Egan LJ. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9(7):584–9.CrossRefPubMed Ali RA, Dooley C, Comber H, Newell J, Egan LJ. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9(7):584–9.CrossRefPubMed
51.
Zurück zum Zitat Vistisen D, Andersen GS, Hansen CS, Hulman A, Henriksen JE, Bech-Nielsen H, et al. Prediction of first cardiovascular disease event in type 1 diabetes: the steno T1 risk engine. Circulation. 2016;133(11):1058–66.CrossRefPubMed Vistisen D, Andersen GS, Hansen CS, Hulman A, Henriksen JE, Bech-Nielsen H, et al. Prediction of first cardiovascular disease event in type 1 diabetes: the steno T1 risk engine. Circulation. 2016;133(11):1058–66.CrossRefPubMed
52.
Zurück zum Zitat Zhou Y, McArdle JJ. Rationale and applications of survival tree and survival ensemble methods. Psychometrika. 2015;80(3):811–33.CrossRefPubMed Zhou Y, McArdle JJ. Rationale and applications of survival tree and survival ensemble methods. Psychometrika. 2015;80(3):811–33.CrossRefPubMed
53.
Zurück zum Zitat Hothorn T, Hornik K, Zeileis A. Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat. 2006;15(3):651–74.CrossRef Hothorn T, Hornik K, Zeileis A. Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat. 2006;15(3):651–74.CrossRef
54.
Zurück zum Zitat Lunyera J, Mohottige D, Von Isenburg M, et al. CKD of uncertain etiology: a systematic review. Clin J Am Soc Nephrol. 2016;11(3):379–85.CrossRefPubMed Lunyera J, Mohottige D, Von Isenburg M, et al. CKD of uncertain etiology: a systematic review. Clin J Am Soc Nephrol. 2016;11(3):379–85.CrossRefPubMed
55.
Zurück zum Zitat Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8 Pt 2):757–63.CrossRefPubMed Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8 Pt 2):757–63.CrossRefPubMed
56.
Zurück zum Zitat Epping-Jordan JE, Galea G, Tukuitonga C, Beaglehole R. Preventing chronic diseases: taking stepwise action. Lancet. 2005;366(9497):1667–71.CrossRefPubMed Epping-Jordan JE, Galea G, Tukuitonga C, Beaglehole R. Preventing chronic diseases: taking stepwise action. Lancet. 2005;366(9497):1667–71.CrossRefPubMed
Metadaten
Titel
Application of survival tree analysis for exploration of potential interactions between predictors of incident chronic kidney disease: a 15-year follow-up study
verfasst von
Azra Ramezankhani
Maryam Tohidi
Fereidoun Azizi
Farzad Hadaegh
Publikationsdatum
01.12.2017
Verlag
BioMed Central
Erschienen in
Journal of Translational Medicine / Ausgabe 1/2017
Elektronische ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-017-1346-x

Weitere Artikel der Ausgabe 1/2017

Journal of Translational Medicine 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.